App-Quantinova.ai

Variation in the current follow-up practice after liver resection for colorectal cancer liver metastases in the UK

N. Mowbray - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

An International Multi-centre Appraisal of the Management of Acute CHOLEcystitis during the COVID-19 Pandemic: The CHOLECOVID Study

H.V. Spiers - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Benefits of Laparoscopy for Major Liver Resection in Cirrhotic Patients: Time for Pushing Indications Beyond the Limits? A Propensity Score Matched Analysis

A. Benedetti Cacciaguerra - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Impact of Gastric Resection and Enteric Anastomotic Configuration on Delayed Gastric Emptying after Pancreaticoduodenectomy: A Network Meta-analysis of Randomized Trials

C. Varghese - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Gastroparesis

N/A

Impact of Lymph Node Ratio on Survival in the Histopathological Subtypes of Resected Ampullary Cancer: A Retrospective International Multicenter Cohort Study

D.H. Lemmers - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Ampullary carcinoma

N/A

Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients with Resected Ampullary Adenocarcinoma

D.H. Lemmers - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Ampullary adenocarcinoma

N/A

The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer

S. Dreyer - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreato-biliary malignancies

N/A

Routine Examination of Gallbladder Specimens after Cholecystectomy: Analysis of the Incidence, Clinical and Histopathological aspects of incidental gallbladder carcinoma

D. Di Mauro - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Gallbladder cancer

N/A

Artificial intelligence in the detection, characterisation and prediction of hepatocellular carcinoma

M. Kawka - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

A fast-track surgery program leads to timelier treatment and higher resection rates in pancreatic cancer

N. De' Liguori Carino - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreato-biliary malignancies

N/A

A meta-analysis evaluating the impact of high-intensity focused ultrasound (HIFU) on survival and pain relief of patients with locally advanced pancreatic cancer

M. Fergadi - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreato-biliary malignancies

N/A

Analgesic modalities and outcomes in acute pancreatitis: systematic review and meta-analysis

N. Thavanesan - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Pancreatitis

N/A

Contrast-enhanced intraoperative ultrasound (CE-IOUS) in patients with pancreatic cancer undergoing surgery: an initial experience

M. Fergadi - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreato-biliary malignancies

Sulfur hexafluoride

CT-PET use in potentially resectable pancreatic cancer

S. McKay - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreato-biliary malignancies

N/A

Diagnostic pathway and 12-month outcome of elderly patients undergoing surgery for suspected pancreatic adenocarcinoma in the United Kingdom

T. Thorne - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreatic cancer

N/A

Management of refractory post liver transplant ascites in a DDLT cohort

M. Al-Zoubi - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Colorectal liver metastases - novel assessment tools for resectability (The CoNoR Study): results from an international questionnaire of hepatopancreatobiliary surgeons

K. Parmar - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Delayed cholecystectomy following endoscopic retrograde pancreatography is not associated with worse surgical outcomes

J. Franklyn - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Evaluation of perioperative troponin levels as a prognostic factor for morbidity/mortality following hepato-pancreato-biliary surgery: early outcomes

E. Tatsios - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Is there seasonal variation in gallstone related admissions in England? a retrospective cohort study of 396 879 admissions

A. Taib - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Gallbladder disease

N/A

Filters

45280 Abstracts